B · Normal
[A U.S. company files a Section 337 investigation application for certain spectral flow cytometry systems and their components] On November 10, the Ministry of Commerce announced that on October 8, 2026, Cytek Biosciences, Inc. filed an application with the U.S. International Trade Commission in accordance with Section 337 of the U.S. Tariff Act of 1930, accusing certain spectral flow cytometry systems and components (Certain Spectral Flow Cytometry Systems and Components) exported to, imported and sold in the United States. Thereof) infringed its patent rights, requested to initiate a Section 337 investigation and issue a limited exclusion order and injunction. Two companies from the United States and China were involved in the case.
Comments